Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion type Assertion NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_head.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion wasGeneratedBy ECO_0000203 NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_provenance.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion wasDerivedFrom befree-20140225 NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_provenance.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion SIO_000772 16799619 NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_provenance.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion evidence source_evidence_literature NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_provenance.
- NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_assertion description "[The second set of genetic alterations are etiological nonspecific, it includes recurrent gains and losses of chromosomes, alteration of TP53 gene, activation of WNT/beta-catenin pathway through CTNNB1/beta-catenin and AXIN (axis inhibition protein) mutations, inactivation of retinoblastoma and IGF2R (insulin-like growth factor 2 receptor) pathways through inactivation of RB1 (retinoblastoma 1), P16 and IGF2R.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711484.RAI89NmvTe-tOLyy7OxXx4CbTEK_mQicjGBPYuLxbQ-AM130_provenance.